We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
351
Dell
DELL
$239B
$5.85M 0.04%
145,362
-4,649
-3% -$184K
LEGN icon
352
Legend Biotech
LEGN
$3.65B
$5.79M 0.04%
116,026
– –
VLO icon
353
Valero Energy
VLO
$89.5B
$5.78M 0.04%
45,574
-2,571
-5% -$323K
ROP icon
354
Roper Technologies
ROP
$40.4B
$5.71M 0.04%
13,206
-1,213
-8% -$500K
WST icon
355
West Pharmaceutical
WST
$23.7B
$5.66M 0.04%
24,056
-1,449
-6% -$343K
AKAM icon
356
Akamai
AKAM
$15.6B
$5.64M 0.04%
66,898
+8,397
+14% +$731K
MSI icon
357
Motorola Solutions
MSI
$72.1B
$5.48M 0.04%
21,259
-11,580
-35% -$2.89M
FIS icon
358
Fidelity National Information Services
FIS
$24.2B
$5.35M 0.04%
78,865
-13,724
-15% -$975K
MCK icon
359
McKesson
MCK
$104B
$5.33M 0.04%
14,200
-2,179
-13% -$813K
PODD icon
360
Insulet
PODD
$11.8B
$5.29M 0.04%
17,986
-39,670
-69% -$10.9M
BNS icon
361
Scotiabank
BNS
$105B
$5.29M 0.04%
108,113
-16,928
-14% -$835K
IFF icon
362
International Flavors & Fragrances
IFF
$20.3B
$5.28M 0.04%
50,346
+3,063
+6% +$301K
AVT icon
363
Avnet
AVT
$6.86B
$5.27M 0.04%
126,771
-99,833
-44% -$4.15M
KPTI icon
364
Karyopharm Therapeutics
KPTI
$155M
$5.22M 0.04%
102,335
+13,333
+15% +$924K
APH icon
365
Amphenol
APH
$185B
$5.17M 0.03%
135,690
-14,000
-9% -$530K
CARR icon
366
Carrier Global
CARR
$49.4B
$5.16M 0.03%
125,145
-13,040
-9% -$529K
DD icon
367
DuPont de Nemours
DD
$18.6B
$5.14M 0.03%
59,612
-1,044
-2% -$83.4K
CHTR icon
368
Charter Communications
CHTR
$17.3B
$5.1M 0.03%
15,047
-7,693
-34% -$2.7M
IDYA icon
369
IDEAYA Biosciences
IDYA
$3.43B
$5.09M 0.03%
280,317
+25,000
+10% +$421K
IT icon
370
Gartner
IT
$11.1B
$5.07M 0.03%
15,082
-1,706
-10% -$551K
PCAR icon
371
PACCAR
PCAR
$70.5B
$5.06M 0.03%
76,725
-21,893
-22% -$1.43M
VOYA icon
372
Voya Financial
VOYA
$8.96B
$5M 0.03%
+81,250
New +$5.21M
WPC icon
373
W.P. Carey
WPC
$17B
$5M 0.03%
65,261
-72,184
-53% -$5.42M
TWST icon
374
Twist Bioscience
TWST
$5.32B
$4.98M 0.03%
209,360
+106,000
+103% +$3.07M
ADM icon
375
Archer Daniels Midland
ADM
$38.7B
$4.94M 0.03%
53,172
-2,877
-5% -$266K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.